Ceftolozane Production Cost Reports

The report provides a detailed analysis essential for establishing a ceftolozane production plant. It encompasses all critical aspects necessary for ceftolozane production, including the cost of ceftolozane production, ceftolozane plant cost, ceftolozane production costs, and the overall ceftolozane production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a ceftolozane production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Ceftolozane is a modern antibiotic compound mainly used to treat serious bacterial infections, particularly those caused by resistant strains. It is primarily utilised in combination with other agents like tazobactam to fight infections caused by drug-resistant gram-negative bacteria. It finds its major application in the treatment of complicated urinary tract infections, abdominal infections, and hospital-acquired pneumonia. It is especially effective against Pseudomonas aeruginosa, which is a tough-to-treat bacterium often found in hospital settings. It is often used in clinical settings where common antibiotics are not effective due to bacterial resistance. It plays an important role in hospitals for managing severe infections in critically ill patients, especially those with weakened immune systems. Moreover, it is also used as a valuable option in antimicrobial therapy programs that focus on controlling the spread of resistant bacterial strains and improving patient outcomes.

The primary factor that drives the market for ceftolozane is its demand as a powerful antibiotic to treat infections caused by gram-negative bacteria resistant to standard antibiotics. Its application as an antibacterial agent for the treatment of complicated intra-abdominal infections and complicated urinary tract infections significantly boosts its demand in the medical and pharmaceutical industries. Its usage as a medication in the treatment of hospital-acquired and ventilator-associated bacterial pneumonia further promotes its demand in the medical and healthcare sectors. Its usage as a drug in combination with tazobactam, a beta-lactamase inhibitor, to improve its effectiveness against certain antibiotic-resistant bacteria also supports its demand in the healthcare sector.

Its demand as a valuable drug in modern antibiotic therapy for its targeted action and ability to work against multi-drug resistant pathogens also drives its market expansion. Additionally, the growing prevalence of antibiotic resistance and the increasing need for advanced hospital-grade treatments continue to drive its demand. Industrial ceftolozane procurement is shaped by several factors, including the availability and cost of major intermediates, compliance with international quality standards, and regulatory approvals across markets. Moreover, innovations in formulation, strong supplier networks, focus on antimicrobial stewardship, and robust cold-chain logistics play a major role in influencing its global distribution and accessibility.

Raw Material for Ceftolozane Production

According to the ceftolozane production plant project report, the major raw materials for ceftolozane production includes 7-aminocephalosporanic acid (7-ACA).

Production Process of Ceftolozane

The extensive ceftolozane production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of ceftolozane sulfate begins with 7-aminocephalosporanic acid (7-ACA), which serves as the core cephalosporin nucleus. The synthesis first involves preparing the main side chain intermediates, including the C-7 acyl side chain precursor (2Z)-2-(5- amino-1,2,4-thiadiazol-3-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetic acid) containing an aminothiadiazole and oxime group. It also involves the preparation of the substituted pyrazole unit required for the C-3 position. The activated C-7 side chain is then coupled to the amino group at the 7-position of the cephem core to form the main antibiotic framework. After this, the pyrazole-based side chain is introduced at the C-3 position to complete the characteristic structure of ceftolozane. Finally, any protecting groups are removed, and the compound is converted into its stable sulfate salt form, which results in the production of ceftolozane sulfate as the desired product.

Ceftolozane is a semi-synthetic, broad-spectrum fifth-generation cephalosporin antibiotic that exerts its bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). It appears as a white to off-white solid, and its molecular formula is C23H30N12O8S2. The molar mass of the compound is 666.69 g/mol. The compound is soluble in dimethyl sulfoxide (DMSO) and has a LogP value of -6.17, which indicates its highly hydrophilic nature. It is marketed under the brand name Zerbaxa in combination with tazobactam, a beta-lactamase inhibitor, and is administered intravenously. The most common adverse reactions associated with its clinical use include nausea, diarrhoea, headache, constipation, and pyrexia. It is contraindicated in patients with known hypersensitivity to cephalosporins, penicillins, or other beta-lactam antibiotics.